<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20171030037093N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-02-23</date_registration>
      <primary_sponsor>Shahre-kord University of Medical Sciences</primary_sponsor>
      <public_title>Effect of breast milk enrichment on early infants</public_title>
      <acronym></acronym>
      <scientific_title>Investigation and comparison of the effect of early and late breast milk enrichment on preterm infants</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-10-07</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/37163</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention.</study_design>
      <phase>2-3</phase>
      <hc_freetext>breast Milk enrichment in preterm infants.</hc_freetext>
      <i_freetext>Intervention 1: First intervention group: On the first day of lactation Infants weighing less than 1000 grams recive  0.5-1  cc / kg  breast  milk every hour, Infants 1000 to 1500 grams recive  2-3 cc / kg  breast  milk every two hours  and Infants weighing over 1600 grams recive  More volume based on their tolerance every 2-3 hours through gavage. After the first day,lactation increases by 10-20 cc/ kg /day and up to 200-100 cc /kg / day.In this group, when the amount of milk received reached 30 cc  kg / day, the interventions begin. in this way 4.4 g of the supplement of aptamil FMS ( NUTRICIA)  is dissolved in each 100 cc of breast milk and it is given to the infant based on the amount of milk received by the infant per day through gavage .it contains 1 g of protein, 0g of fat, 2.7g of carbohydrate and a certain amount of some salts and vitamins.Breast milk enrichment continues for up to 4 weeks after birth. Intervention 2: Second intervention group: On the first day of lactation Infants weighing less than 1000 grams recive  0.5-1  cc / kg  breast  milk every hour, Infants 1000 to 1500 grams recive  2-3 cc / kg  breast  milk every two hours  and Infants weighing over 1600 grams recive  More volume based on their tolerance every 2-3 hours through gavage. After the first day,lactation increases by 10-20 cc/ kg /day and up to 200-100 cc /kg / day.In this group, when the amount of milk received reached 70 cc  kg / day, the interventions begin. in this way 4.4 g of the supplement of aptamil FMS ( NUTRICIA)  is dissolved in each 100 cc of breast milk and it is given to the infant based on the amount of milk received by the infant per day through gavage .it contains 1 g of protein, 0g of fat, 2.7g of carbohydrate and a certain amount of some salts and vitamins.Breast milk enrichment continues for up to 4 weeks after birth. Intervention 3: Third intervention group:On the first day of lactation Infants weighing less than 1000 grams recive  0.5-1  cc / kg  breast  milk every hour, Infants 1000 to 1500 grams recive  2-3 cc / kg  breast  milk every two hours  and Infants weighing over 1600 grams recive  More volume based on their tolerance every 2-3 hours through gavage. After the first day,lactation increases by 10-20 cc/ kg /day and up to 200-100 cc /kg / day.In this group, when the amount of milk received reached 100 cc  kg / day, the interventions begin. in this way 4.4 g of the supplement of aptamil FMS ( NUTRICIA)  is dissolved in each 100 cc of breast milk and it is given to the infant based on the amount of milk received by the infant per day through gavage .it contains 1 g of protein, 0g of fat, 2.7g of carbohydrate and a certain amount of some salts and vitamins.Breast milk enrichment continues for up to 4 weeks after birthount of some salts and vitamins.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is data will be kept private.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Majid Hamidi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahrekord University of Medical Sciences, Building No. 2, University headquarters, Ayatollah Kashani Blvd</address>
        <city>Shahrekord</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8815713471</zip>
        <telephone>+98 38 3227 4004</telephone>
        <email>majid.hamidi@yahoo.com</email>
        <affiliation>Shahre-kord University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Majid Hamidi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahrekord University of Medical Sciences, Building No. 2, University headquarters, Ayatollah Kashani Blvd</address>
        <city>Shahrekord</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8815713471</zip>
        <telephone>+98 38 3227 4004</telephone>
        <email>majid.hamidi@yahoo.com</email>
        <affiliation>Shahre-kord University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Premature infants (28-32 weeks) weighing less than 2000 grams
entery the study  With the consent of the infant's parents</inclusion_criteria>
      <agemin>1 day</agemin>
      <agemax>28 days</agemax>
      <gender>Both</gender>
      <exclusion_criteria>any Congenital anomalies
Formula feeding</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>P07.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Preterm [premature] newborn [other]</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>First intervention group: On the first day of lactation Infants weighing less than 1000 grams recive  0.5-1  cc / kg  breast  milk every hour, Infants 1000 to 1500 grams recive  2-3 cc / kg  breast  milk every two hours  and Infants weighing over 1600 grams recive  More volume based on their tolerance every 2-3 hours through gavage. After the first day,lactation increases by 10-20 cc/ kg /day and up to 200-100 cc /kg / day.In this group, when the amount of milk received reached 30 cc  kg / day, the interventions begin. in this way 4.4 g of the supplement of aptamil FMS ( NUTRICIA)  is dissolved in each 100 cc of breast milk and it is given to the infant based on the amount of milk received by the infant per day through gavage .it contains 1 g of protein, 0g of fat, 2.7g of carbohydrate and a certain amount of some salts and vitamins.Breast milk enrichment continues for up to 4 weeks after birth</i_keyword>
      <i_keyword>Second intervention group: On the first day of lactation Infants weighing less than 1000 grams recive  0.5-1  cc / kg  breast  milk every hour, Infants 1000 to 1500 grams recive  2-3 cc / kg  breast  milk every two hours  and Infants weighing over 1600 grams recive  More volume based on their tolerance every 2-3 hours through gavage. After the first day,lactation increases by 10-20 cc/ kg /day and up to 200-100 cc /kg / day.In this group, when the amount of milk received reached 70 cc  kg / day, the interventions begin. in this way 4.4 g of the supplement of aptamil FMS ( NUTRICIA)  is dissolved in each 100 cc of breast milk and it is given to the infant based on the amount of milk received by the infant per day through gavage .it contains 1 g of protein, 0g of fat, 2.7g of carbohydrate and a certain amount of some salts and vitamins.Breast milk enrichment continues for up to 4 weeks after birth.</i_keyword>
      <i_keyword>Third intervention group:On the first day of lactation Infants weighing less than 1000 grams recive  0.5-1  cc / kg  breast  milk every hour, Infants 1000 to 1500 grams recive  2-3 cc / kg  breast  milk every two hours  and Infants weighing over 1600 grams recive  More volume based on their tolerance every 2-3 hours through gavage. After the first day,lactation increases by 10-20 cc/ kg /day and up to 200-100 cc /kg / day.In this group, when the amount of milk received reached 100 cc  kg / day, the interventions begin. in this way 4.4 g of the supplement of aptamil FMS ( NUTRICIA)  is dissolved in each 100 cc of breast milk and it is given to the infant based on the amount of milk received by the infant per day through gavage .it contains 1 g of protein, 0g of fat, 2.7g of carbohydrate and a certain amount of some salts and vitamins.Breast milk enrichment continues for up to 4 weeks after birthount of some salts and vitamins.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Infant's weight. Timepoint: At the beginning of birth and 4 weeks after birth. Method of measurement: Scale.</prim_outcome>
      <prim_outcome>Infant's head circumference. Timepoint: At the beginning of birth and 4 weeks after birth. Method of measurement: Meter.</prim_outcome>
      <prim_outcome>Infant's height. Timepoint: At the beginning of birth and 4 weeks after birth. Method of measurement: Meter.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahre-kord University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-09-23</approval_date>
        <contact_name>Ethics Committee of Shahrekord University of Medical Sciences</contact_name>
        <contact_address>Vice chancellor for research, Building No. 2, University headquarters, Ayatollah Kashani Blvd Shahrekord Chahar-Mahal-va-Bakhtiari Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
